Search bioRxiv⌕ Search

bioRxiv · 10.1101/2023.08.21.554143

Ocular TRPV1 deficiency protects from dry eye-induced corneal nerve damage

Abstract

BackgroundCorneal nerve damage causes the most clinically significant symptoms in dry eye disease (DED) yet its pathophysiology remains poorly understood. Transient receptor potential vanilloid-1 (TRPV1) channels abound in corneal nerve fibers and respond to inflammation-derived ligands, which increase in DED. TRPV1 overactivation promotes axonal degeneration in vitro but whether it contributes to corneal neuropathy is unknown. Therefore, here we explored the role of TRPV1 in DED-associated corneal nerve damage. MethodsSurgical DED was induced in TRPV1-deficient (TRPV1KO) and wild-type (wt) mice. Corneal nerve function was measured on days 0, 5, and 10 by mechanical and capsaicin sensitivity and eye-closing ratio as an indicator of non-evoked pain. Nerve and epithelial morphology was evaluated by confocal microscopy of corneal wholemounts. Pharmacological TRPV1 inhibition in wild-type mice was also evaluated. Resultswt and TRPV1KO mice developed comparable ocular desiccation and corneal epithelial damage. Contrasting with wt mice, corneal mechanosensitivity in TRPV1KO mice did not decrease with disease progression. Capsaicin sensitivity increased in wt mice with DED, and consistently, wt but not TRPV1KO mice with DED displayed signs of non-evoked pain. Wt mice with DED exhibited nerve degeneration throughout the corneal epithelium whereas TRPV1KO mice only developed a reduction in the most superficial nerve endings that failed to propagate to the deeper subbasal corneal nerves. Pharmacological blockade of ocular TRPV1 activity reproduced these findings in wt mice with DED. Although TRPV1KO mice with DED had fewer pathogenic Th1 and Th17 CD4+ T cells in the lymph nodes, conjunctival immune infiltration was comparable between strains. Moreover, CD4+ T cells from wt and TRPV1KO mice with DED were equally pathogenic when transferred into T cell-deficient mice, confirming that TRPV1 activity in T cells is not involved in corneal neuropathy. ConclusionsAlthough ocular desiccation is sufficient to trigger superficial corneal nerve damage in DED, proximal propagation of axonal degeneration requires TRPV1 signaling. Conversely, local inflammation sensitizes ocular TRPV1 channels, which are also involved in ocular pain, a key symptom of the disease. Thus, our findings suggest that ocular TRPV1 overactivation is a driving force in DED-associated corneal neuropathy and a potential therapeutic target. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=63 SRC="FIGDIR/small/554143v1_ufig1.gif" ALT="Figure 1"> View larger version (29K): org.highwire.dtl.DTLVardef@12d43d7org.highwire.dtl.DTLVardef@c11354org.highwire.dtl.DTLVardef@1dc0098org.highwire.dtl.DTLVardef@ab2e60_HPS_FORMAT_FIGEXP M_FIG C_FIG

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Pizzano, M., Vereertbrugghen, A., Cernutto, A., Sabbione, F., Keitelman, I. A., Shiromizu, C. M., Aguilar, D. V., Fuentes, F., Giordano, M. N., Trevani, A. S., Galletti, J. G.. 2023-08-22. Ocular TRPV1 deficiency protects from dry eye-induced corneal nerve damage. https://doi.org/10.1101/2023.08.21.554143

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗